Jesse M. Cedarbaum
16Patents
7h-index
14Co-inventors
59Inventor score
Filing activity: Jan 15, 1999 → Jul 12, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7354581B2 | Therapeutic combination of a VEGF antagonist and anti-hypertensive agent | Chemistry; Metallurgy | 40 | Active |
| US7531172B2 | Methods of treating diseases with a VEGF antagonist | Human Necessities | 28 | Active |
| US7449182B2 | Therapeutic combination of a VEGF antagonist and anti-hypertensive agent | Chemistry; Metallurgy | 24 | Active |
| US7351411B2 | Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF) | Chemistry; Metallurgy | 22 | Active |
| US7482002B2 | Method of administering and using VEGF inhibitors for the treatment of prostate cancer | Chemistry; Metallurgy | 21 | Active |
| US7354582B2 | Use of VEGF antagonists for the treatment of malignant gliomas | Chemistry; Metallurgy | 11 | Expired |
| US7354580B2 | Method of administering and using VEGF inhibitors for the treatment of human cancer | Chemistry; Metallurgy | 11 | Expired |
| US7479274B2 | Method of administering and using VEGF inhibitors for the treatment of pancreatic carcinoma | Chemistry; Metallurgy | 7 | Active |
| US7479273B2 | Method of administering and using VEGF inhibitors for the treatment of renal cell cancer | Chemistry; Metallurgy | 7 | Active |
| US8388963B2 | Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof | Human Necessities | 7 | Active |
| US7479272B2 | Method of administering and using VEGF inhibitors for the treatment of breast cancer | Chemistry; Metallurgy | 7 | Active |
| US7482001B2 | Method of administering and using VEGF inhibitors for the treatment of non small cell lung cancer | Chemistry; Metallurgy | 7 | Active |
| US7479275B2 | Method of administering and using VEGF inhibitors for the treatment of colorectal cancer | Chemistry; Metallurgy | 7 | Active |
| US6656474B1 | Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders | Human Necessities | 2 | Expired |
| US10272082B2 | Combination ALS therapy | Human Necessities | 1 | Active |
| US8748496B2 | Methods of treatment of hyperuricemia and associated disease states | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.